LEADER 01686oam  2200421   450 
001 9910707721803321
005 20161117144833.0
035   $a(CKB)5470000002467333
035   $a(OCoLC)606486026$z(OCoLC)652258695$z(OCoLC)667355741
035   $a(EXLCZ)995470000002467333
100   $a20100411d1996      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare End-Stage Renal Disease (kidney failure) Program $ehearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Fourth Congress, first session, April 3, 1995
210  1$aWashington :$cU.S. Government Printing Office :$cFor sale by the Superintendent of Documents, U.S. Government Printing Office, Congressional Sales Office,$d1996.
215   $a1 online resource (iii, 165 pages) $cillustrations
320   $aIncludes bibliographical references.
517   $aMedicare End-Stage Renal Disease 
606   $aChronic renal failure$xTreatment$zUnited States$xFinance
606   $aHemodialysis$zUnited States$xFinance
606   $aKidneys$xTransplantation$zUnited States$xFinance
608   $aLegislative hearings.$2lcgft
615  0$aChronic renal failure$xTreatment$xFinance.
615  0$aHemodialysis$xFinance.
615  0$aKidneys$xTransplantation$xFinance.
801  0$bOCLCE
801  1$bOCLCE
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910707721803321
996   $aMedicare End-Stage Renal Disease (kidney failure) Program$93535266
997   $aUNINA